Clinical, biologic, and outcome differences according to MIBG avidity in children with neuroblastoma: A report from the Children’s Oncology Group (COG)

Authors :: Gregory A. Yanik
John M. Maris
Julie R. Park
Collin Van Ryn
Steven G. DuBois
Arlene Naranjo
Marguerite T. Parisi
Katherine K. Matthay
David L. Baker
Vandana Batra
Susan G. Kreissman
Barry L. Shulkin
Rajen Mody
Source :: Journal of Clinical Oncology. 34:10526-10526
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 10526Background: Prior investigations suggest that neuroblastomas (NBL) that do not accumulate MIBG (MIBG non-avid) may have more favorable features compared to MIBG avid tumors. We compared clinic...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Cog
business.industry
Neuroblastoma
Internal medicine
medicine
chemical and pharmacologic phenomena
Avidity
medicine.disease
business

Full Text Access

Tools